Spasticity Clinical Trials

7 recruiting

Frequently Asked Questions

Common questions about Spasticity clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Not Applicable

Upper Limb Nerve Cryoneurolysis is Non Inferior to the Usual Care and Has Therapeutic Add Value in Dealing With Shoulder Pain and Functional Problems Caused by Spasticity and Motor Impairment

Traumatic Brain InjuryStrokeMultiple Sclerosis+5 more
Centre National de Rééducation Fonctionnelle et de Réadaptation50 enrolled1 locationNCT06782464
Recruiting

Classification of Upper and Lower Limb Spasticity Patterns and Their Impact on Quality of Life in Patients With Multiple Sclerosis

Multiple SclerosisSpasticitySpasticity With Multiple Sclerosis
Marmara University75 enrolled1 locationNCT07466823
Recruiting
Phase 2

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

Multiple Sclerosis Spasticity
Celgene200 enrolled53 locationsNCT06782490
Recruiting
Not Applicable

At Home Use of Stimulation Suits for Managing MS Symptoms

Multiple SclerosisSpasticityAtaxia - Other+5 more
Daphne Kos70 enrolled2 locationsNCT07202195
Recruiting

The Myelin Disorders Biorepository Project

AdrenoleukodystrophyCockayne SyndromeRefsum Disease+63 more
Children's Hospital of Philadelphia12,000 enrolled23 locationsNCT03047369
Recruiting

Analysis of Balance Disorders After Botulinum Toxin Treatment in the Rectus Femoris in Patients With a Stiff Knee Gait

Spasticity With Multiple SclerosisBotulinum Toxin InjectionStiff Knee Gait+3 more
Hopital Nord Franche-Comte15 enrolled1 locationNCT07108920
Recruiting
Not Applicable

Dry Needling in Multiple Sclerosis

Multiple SclerosisSpasticity
University of Kansas Medical Center24 enrolled1 locationNCT06394310
Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Multiple Endocrine Neoplasia Type 1Multiple Endocrine Neoplasia Type 2Rare Disorders+337 more
Sanford Health20,000 enrolled2 locationsNCT01793168
Recruiting

Neuroimmunology Registry and Biobank

EpilepsyMovement DisordersSpasticity+5 more
Charite University, Berlin, Germany300 enrolled2 locationsNCT06958341
Recruiting

Neurosurgical Outcome Network

DepressionTrigeminal NeuralgiaObsessive-Compulsive Disorder+20 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta4,500 enrolled27 locationsNCT06724029
Recruiting
Not Applicable

EXOPULSE Mollii Suit, Motor Function & Multiple Sclerosis (EXOSEP 2)

Sclerosis, MultipleMS (Multiple Sclerosis)Spasticity, Muscle+1 more
Sheikh Shakhbout Medical City36 enrolled1 locationNCT05857280
Recruiting
Not Applicable

miR-142-3p as Potential Biomarker of Synaptopathy in MS

Multiple SclerosisSpasticity
Neuromed IRCCS1,000 enrolled1 locationNCT03999788